Compugen Ltd. (CGEN) Insider Trading

Last 12 months

Insiders sold $118k and bought nothing on the open market.

All of the selling was scheduled in advance under 10b5-1 plans. No executive or director has bought shares on the open market in the last two years.

Net open-market

−$118k

0 buys · 10 sales

Under a 10b5-1 plan

100%

of the value sold

Insiders who bought / sold

0 / 2

executives and directors

Last open-market buy

None

in the last two years

Get an email when CGEN's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jul 9	Zurit Levine SVP, Business Development	Sold10b5-1 plan	1,875	$2.50	$5k	6.0%	Form 4
Apr 24	Zurit Levine SVP, Business Development	Sold10b5-1 plan	2,000	$3.20	$6k	6.4%	Form 4
Apr 24	Eran Ophir President and CEO	Sold10b5-1 plan	5,000	$3.20	$16k	31%	Form 4
Apr 14	Eran Ophir President and CEO	Sold10b5-1 plan	5,000	$2.90	$15k	31%	Form 4
Apr 14	Zurit Levine SVP, Business Development	Sold10b5-1 plan	2,000	$2.80	$6k	6.4%	Form 4
Apr 10	Zurit Levine SVP, Business Development	Sold10b5-1 plan	3,125	$2.56	$8k	9.6%	Form 4
Apr 7 – 8	Zurit Levine SVP, Business Development	Sold10b5-1 plan 2 parts	7,875	$2.38 average	$19k	21%	Form 4
Apr 1	Zurit Levine SVP, Business Development	Sold10b5-1 plan	3,500	$2.20	$8k	11%	Form 4
Apr 1	Eran Ophir President and CEO	Sold10b5-1 plan	5,625	$2.21	$12k	33%	Form 4
Mar 26	Zurit Levine SVP, Business Development	Sold10b5-1 plan	11,875	$2.04	$24k	29%	Form 4

Jul 910b5-1 plan
Zurit Levine
SVP, Business Development · sold 1,875 at $2.50
$5k
6.0% of stake
Apr 2410b5-1 plan
Zurit Levine
SVP, Business Development · sold 2,000 at $3.20
$6k
6.4% of stake
Apr 2410b5-1 plan
Eran Ophir
President and CEO · sold 5,000 at $3.20
$16k
31% of stake
Apr 1410b5-1 plan
Eran Ophir
President and CEO · sold 5,000 at $2.90
$15k
31% of stake
Apr 1410b5-1 plan
Zurit Levine
SVP, Business Development · sold 2,000 at $2.80
$6k
6.4% of stake
Apr 1010b5-1 plan
Zurit Levine
SVP, Business Development · sold 3,125 at $2.56
$8k
9.6% of stake
Apr 7 – 810b5-1 plan
Zurit Levine
SVP, Business Development · sold 7,875 at avg $2.38
$19k
21% of stake
Apr 110b5-1 plan
Zurit Levine
SVP, Business Development · sold 3,500 at $2.20
$8k
11% of stake
Apr 110b5-1 plan
Eran Ophir
President and CEO · sold 5,625 at $2.21
$12k
33% of stake
Mar 2610b5-1 plan
Zurit Levine
SVP, Business Development · sold 11,875 at $2.04
$24k
29% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CGEN, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Biological Products, (No Diagnostic Substances)

PLXProtalix Biotherapeutics Inc.

RXRXRecursion Pharmaceuticals, Inc.

MGTXMeiraGTx Holdings plc

VIRVir Biotechnology Inc.

CSBRChampions Oncology, Inc.

RGNXRegenxbio Inc.

FDMT4D Molecular Therapeutics, Inc.

IVVDInvivyd Inc.

Spot a number that looks wrong? Check it in CGEN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CGEN

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.